New Modalities, New Tools: Choosing a Flexible Digital Platform for Drug Discovery

As pharmaceutical innovation rapidly evolves, the complexity of data generated from RNA therapeutics, gene therapies, antibody-drug conjugates (ADCs), and protein degraders necessitates a new approach to digital infrastructure. In this exclusive whitepaper by Scientific Computing World, in partnership with Revvity Signals, leading experts from top biotech and pharmaceutical organizations share critical insights on navigating the challenges and opportunities presented by multiple therapeutic modalities.

Discover how modern data strategies, cultural shifts, and the right digital platforms can unlock genuine scientific agility and drive innovation.

Key Topics Covered in the Whitepaper

• Managing data challenges across multiple modalities
• Making informed decisions on data structures
• Promoting collaboration across software platforms and data silos
• Bespoke vs. public data languages and ontologies
• Overcoming cultural challenges in transforming data platforms and structures
• The role of Artificial Intelligence (AI) and Machine Learning (ML) in drug discovery
• Enhancing drug discovery through advanced software platforms

Get the Full Report

Gain actionable insights into building flexible, future-ready digital platforms that empower your drug discovery teams.